A brand new scoring system has the potential to cut back the overuse of empiric antipseudomonal antibiotics in sufferers with persistent obstructive pulmonary illness (COPD) and community-acquired pneumonia (CAP), a brand new examine discovered.
Researchers sought to judge the microbiologic patterns related to threat components for utilizing empiric antibiotic remedy in sufferers with COPD who’re hospitalized for CAP. The investigators carried out a secondary evaluation of the World Initiative for Methicillin-resistant Staphylococcus aureus Pneumonia (GLIMP), a world, multicenter, observational, point-prevalence examine of hospitalized sufferers with COPD and CAP, carried out between March 2015 and June 2015. GLIMP included immunocompetent sufferers with COPD who had been hospitalized with CAP from 37 nations in all continents.
The secondary evaluation of GLIMP concerned 689 sufferers with COPD hospitalized for CAP (imply [SD] age, 72 (11) years; 67% male). Of these sufferers, 11% had very extreme airflow limitation (compelled expiratory quantity in 1 second [FEV1] ≤30%), 10% had bronchiectasis, and 5% had skilled a earlier Pseudomonas aeruginosa an infection. Learn extra right here.